Biliary Sphincteroplasty for Sphincter of Oddi Dysfunction
For patients with sphincter of Oddi dysfunction who have failed medical therapy, endoscopic biliary sphincterotomy (not surgical sphincteroplasty) is the recommended first-line intervention, with treatment success strongly dependent on the presence of objective biliary obstruction findings. 1
Patient Selection Algorithm
The Milwaukee classification system predicts treatment outcomes and should guide intervention decisions:
Group I (Papillary Stenosis) - Strongest Indication
Proceed directly to endoscopic sphincterotomy for patients presenting with all three objective findings: 1, 2
- Elevated liver function tests (bilirubin, AST, ALT, ALP, GGT) during pain episodes
- Dilated common bile duct on imaging
- Delayed contrast drainage on ERCP
Expected outcomes: 90.5% complete pain relief with endoscopic sphincterotomy 2, and surgical sphincteroplasty shows 62% good results in this group 3
Group II (Intermediate) - Conditional Indication
Consider endoscopic sphincterotomy for patients with biliary-type pain plus one or two of the Group I objective findings 2, 4
Expected outcomes: 75% complete pain relief with endoscopic sphincterotomy 2
Group III (Functional) - Weakest Indication
Exercise caution in patients with only biliary-type pain without objective findings 2, 5
Expected outcomes: Only 50% complete pain relief with endoscopic sphincterotomy 2, and very low-certainty evidence shows sphincterotomy may have little to no effect versus sham (RR 1.05,95% CI 0.66-1.66) 5
Treatment Approach
First-Line: Endoscopic Sphincterotomy
Biliary sphincterotomy via ERCP is the primary treatment for sphincter of Oddi dysfunction, particularly in post-cholecystectomy patients 1, 6, 7
Pre-procedure requirements: 1
- Full blood count and INR/PT to identify coagulopathy or thrombocytopenia
- Manage anticoagulants per BSG/ESGE guidelines
- Administer rectal NSAIDs (100mg diclofenac or indomethacin) to reduce post-ERCP pancreatitis risk
Technical considerations: 1, 7
- Competency in access papillotomy is essential
- For difficult biliary access, endoscopic papillary balloon dilation (EPBD) can be used as an adjunct to sphincterotomy
- In patients with uncorrected coagulopathy, EPBD alone (8mm balloon) may be considered as an alternative
Second-Line: Surgical Sphincteroplasty
Surgical transduodenal sphincteroplasty with transampullary septectomy should be reserved for patients who fail endoscopic therapy 8, 3
Patient selection for surgery: 8
- Objective features of biliary obstruction (delayed isotope excretion or elevated sphincter pressures)
- Morphine 99mTc-TBIDA scintigraphy can reliably identify surgical candidates (100% positive predictive value, 100% sensitivity, 92% specificity in one series)
- Sphincter of Oddi manometry is not essential for diagnosis
- Median follow-up 5.1 years shows significant pain reduction (16 vs. 67 pre-operatively, p=0.003)
- 95% median patient satisfaction
- Better outcomes in biliary versus pancreatic presentations (62% vs. 40% good results, though not statistically significant)
Critical Pitfalls
Avoid sphincterotomy in Group III patients without careful counseling - only 50% respond favorably, and recent Cochrane evidence shows very low certainty of benefit versus sham 2, 5
Do not perform sphincterotomy without pre-procedure coagulation studies - bleeding is a recognized complication requiring FBC and INR/PT assessment 1
Recognize that sphincter of Oddi manometry is not mandatory - clinical classification and objective findings (particularly delayed drainage on hepatobiliary scintigraphy) can guide treatment decisions 8, 4
Previous cholecystectomy status does not predict response - 85% of cholecystectomized patients and 81.3% with intact gallbladder respond to endoscopic sphincterotomy 2
Complications Management
For acute cholangitis with failed antibiotic response or septic shock: urgent biliary decompression via ERCP with sphincterotomy and/or stenting is required 1, 6
Post-ERCP pancreatitis prevention: 1, 7
- Rectal NSAIDs (100mg) should be administered to all patients without contraindications
- Consider pancreatic stent placement if repeated pancreatic duct cannulation occurs (>1 wire passage)
- Avoid pancreatic duct cannulation or contrast-filling when possible